The Athena Clinical Trial (Addipose-derived regenerative cells in the Treatment of patients with chronic ischmemic HEart disease Not Amenable to surgical or interventional revascularization) will enroll 45 patients in multiple centers in the United States. The study doctor and team will assess whether or not you are eligible to participate in the study. However, the major qualifications to participate in this study are:
•you have coronary heart disease (poor blood flow to the heart)
•you are not a candidate for coronary artery bypass surgery, stents or balloon angioplasty
•you are able to undergo a liposuction procedure (a procedure to remove approximately 1½ cups of fat tissue from your body)
If you think you or someone you know may be eligible for the ATHENA clinical trial please contact the study/intake coordinator.
Also for more information visit www.theathenatrial.com
For more information, contact James Gibbs, RN, CRC at 919-681-4684.